Advanced search
Publication Cover
Acta Oncologica Volume 62, 2023 - Issue 11: 21st Acta Oncologica Symposium—BiGART 2023 - Biology-Guided Adaptive Radiotherapy - Aarhus, Denmark. June 20-21, 2023
Journal homepage
238
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: BiGART 2023 Issue

HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study

Jacob Kinggaard Lilja-Fischera Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark;b Department of Otolaryngology – Head & Neck surgery, Aarhus University Hospital, Aarhus, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6400-6650View further author information
ORCID Icon,
Morten Horsholt Kristensena Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0002-4757-1172View further author information
ORCID Icon,
Pernille Lassena Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0003-1050-7692View further author information
ORCID Icon,
Torben Steinichec Department of Clinical Medicine, Aarhus University, Aarhus, Denmark;d Department of Pathology, Aarhus University Hospital, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0001-5689-3555View further author information
ORCID Icon,
Trine Trammc Department of Clinical Medicine, Aarhus University, Aarhus, Denmark;d Department of Pathology, Aarhus University Hospital, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0003-3894-4552View further author information
ORCID Icon,
Magnus Stougaardc Department of Clinical Medicine, Aarhus University, Aarhus, Denmark;d Department of Pathology, Aarhus University Hospital, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0001-7456-902XView further author information
ORCID Icon,
Christian Maaree Department of Oncology, Herlev Hospital, Herlev, DenmarkORCID Iconhttps://orcid.org/0000-0002-9698-2082View further author information
ORCID Icon,
Jørgen Johansenf Department of Oncology, Odense University Hospital, Odense, DenmarkORCID Iconhttps://orcid.org/0000-0003-3911-3929View further author information
ORCID Icon,
Hanne Primdahlg Department of Oncology, Aarhus University Hospital, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0003-3562-0026View further author information
ORCID Icon,
Claus Andrup Kristensenh Department of Oncology, Copenhagen University Hospital, Copenhagen, DenmarkORCID Iconhttps://orcid.org/0000-0002-6250-0161View further author information
ORCID Icon,
Maria Anderseni Department of Oncology, Aalborg University Hospital, Aalborg, DenmarkORCID Iconhttps://orcid.org/0000-0002-6598-9740View further author information
ORCID Icon,
Jesper Grau Eriksena Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0002-1145-6033View further author information
ORCID Icon &
Jens Overgaarda Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0002-0814-8179View further author information
ORCID Icon show all
Pages 1384-1388 | Received 14 Aug 2023, Accepted 28 Sep 2023, Published online: 14 Oct 2023

References

  • Lassen P. The role of human papillomavirus in head and neck cancer and the impact on radiotherapy outcome. Radiother Oncol. 2010;95(3):371–380. doi: 10.1016/j.radonc.2010.04.022.
  • Lassen P, Eriksen JG, Hamilton-Dutoit S, et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009;27(12):1992–1998. doi: 10.1200/JCO.2008.20.2853.
  • Lassen P, Huang SH, Su J, et al. Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: large-scale comparison of DAHANCA vs PMH cohorts. Int J Cancer. 2022;150(8):1329–1340. doi: 10.1002/ijc.33876.
  • Lilja-Fischer JK, Ulhøi BP, Alsner J, et al. Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts. Acta Oncol. 2019;58(10):1489–1494. doi: 10.1080/0284186X.2019.1660802.
  • Lassen P, Overgaard J. Scoring and classification of oropharyngeal carcinoma based on HPV-related p16-expression. Radiother Oncol. 2012;105(2):269–270. doi: 10.1016/j.radonc.2012.09.017.
  • IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 90. Lyon, France: IARC; 2007. p. 1–636.
  • Eriksen JG, Maare C, Johansen J, et al. 5-Y update of the randomized phase III trial DAHANCA19: primary (chemo) RT +/- zalutumumab in HNSCC. Radiother. Oncol. 2018;127: S137–S138. doi: 10.1016/S0167-8140(18)30581-4.
  • Jensen K, Friborg J, Hansen CR, et al. The danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines. Radiother Oncol. 2020;151:149–151. doi: 10.1016/j.radonc.2020.07.037.
  • Andersen K, Holm K, Tranberg M, et al. Targeted next generation sequencing for human papillomavirus genotyping in cervical Liquid-Based cytology samples. Cancers (Basel). 2022;14(3):652. doi: 10.3390/cancers14030652.
  • El-Naggar AK, Westra WH. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck. 2012;34(4):459–461. doi: 10.1002/hed.21974.
  • Mehanna H, Taberna M, von Buchwald C, et al. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis. Lancet Oncol. 2023;24(3):239–251. doi: 10.1016/S1470-2045(23)00013-X.
  • Larsen CG, Jensen DH, Carlander A-LF, et al. Novel nomograms for survival and progression in HPV + and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients. Oncotarget. 2016;7(44):71761–71772. doi: 10.18632/oncotarget.12335.
  • Bentzen J, Toustrup K, Eriksen JG, et al. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study. Acta Oncol. 2015;54(7):1001–1007. doi: 10.3109/0284186X.2014.992547.
  • Lassen P, Alsner J, Andrup Kristensen C, et al. OC-0105: Incidence and survival after HPV + and HPV- oropharynx cancer in Denmark 1986-2020 - A DAHANCA study. Radiother Oncol. 2023;182: S66–S67. doi: 10.1016/S0167-8140(23)08519-5.
  • Mehanna H, Robinson M, Hartley A, et al. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet. 2019;393(10166):51–60. doi: 10.1016/S0140-6736(18)32752-1.
  • Gillison ML, Trotti AM, Harris J, et al. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet. 2019;393(10166):40–50. doi: 10.1016/S0140-6736(18)32779-X.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.